The Death of a Disease: A History of the Eradication of Poliomyelitis

References

153 References “Acute Flaccid Paralysis Associated with Circulating Vaccine-Derived Poliovirus, Philippines, 2001.” MMWR 50, no. 40 (October 12, 2001). Alexander, J. P., et al. “Duration of Poliovirus Excretion and Its Implications for Acute Flaccid Paralysis Surveillance: A Review of the Literature.” Journal of Infectious Diseases 175, Suppl. 1 (1997): S176–S182. “Apparent Global Interruption of Wild Poliovirus Type 2 Transmission .” MMWR 50, no. 12 (March 30, 2001). Bart, K. J., J. Foulds, and P. Patriarca. “Global Eradication of Poliomyelitis : Benefit-Cost Analysis.” Bulletin of the World Health Organization 74, no. 1 (1996): 35–45. Bator, Paul A. Within Reach of Everyone: A History of the University of Toronto School of Hygiene and the Connaught Laboratories, vol. 1 (1927 to 1955) and vol. 2, with Andrew J. Rhodes (1955– 1975). The Canadian Public Health Association, 1990 and 1995. Beale, John A. “The Development of IPV.” In Vaccinia, Vaccination and Vaccinology: Jenner, Pasteur and Their Successors, edited by S. Plotkin and B. Fantini. Paris: Elsevier, 1996. Bellmunt, A., et al. “Evolution of Poliovirus Type I during 5.5 Years of Prolonged Enteral Replication in an Immunodeficient Patient.” Virology 265 (1999): 178–184. Benison, Saul. “International Medical Cooperation: Dr. Albert Sabin, Live Poliovirus Vaccine and the Soviets.” Bulletin of the History of Medicine 56 (1982): 460–483. Benison, Saul. Tom Rivers: Reflections on a Life in Medicine and Science . Cambridge, MA: MIT Press, 1968. Berry, N., C. Davis, A. Jenkins, D. Wood, P. Minor, G. Schild, M. Bottiger, H. Holmes, and N. Almond. “Vaccine Safety: Analysis of Oral Polio Vaccine CHAT Stocks.” Nature 410 (2001): 1046. Blancou, P., J. P. Vartanian, C. Christopherson, N. Chenciner, C. Basilico, S. Kwok, and S. Wain-Hobson. “Polio Vaccine Samples Not Linked to AIDS.” Nature 410 (2001): 1045. Bodian, D., et al. “Differentiation of Types of Poliomyelitis Viruses.” American Journal Hygiene 49 (1949): 234–245. 154 References Carter, Richard. The Gentle Legions. New York: Doubleday, 1961. Cello, J., et al. “Chemical Synthesis of Poliovirus cDNA.” Sciencexpress , www.sciencexpress.org, July 11, 2002. Chumakov, Mikhail et al. “Some Results of the Work on Mass Immunization in the Soviet Union with Live Poliovirus Vaccine Prepared from Sabin Strains.” Bulletin of the World Health Organization 25 (1961): 79–91. “Circulation of a Type 2 Vaccine-Derived Poliovirus, Egypt, 1952– 1993.” MMWR 50, no. 3 (January 26, 2001). Clarke, Tom. “WHO Vaccinates 16 Million.” Nature Scienceupdate, July 13, 2001. “Confinement des Stocks de Poliovirus Sauvage.” Geneva: World Health Organization, January 2002. “Conquering the Dreaded Crippler, Polio,” http://detnews.com. Detroit News website: Rearview Mirror. Dalakas, M. C., et al. “Late Post-poliomyelitis Muscular Atrophy: Clinical, Virologic, and Immunologic Studies.” Reviews of Infectious Diseases 6, Suppl. 2 (1984): S562–S567. Defries, Robert D. The First Forty Years, 1914–1955: Connaught Medical Research Laboratories, University of Toronto. Toronto: University of Toronto Press, 1968. Enders, J. F., et al. “Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues.” Science 109 (1949): 85–87. “Eradication of Poliomyelitis.” Report by the World Health Organization Secretariat, Geneva, November 21, 2002. Fondation Marcel Mérieux, à Lyon depuis 1897. Lyon: Marcel Mérieux Foundation. Heim, A. “Prolonged Excretion of Vaccine-Derived Poliovirus in Immunodeficient Patients.” Recent Research and Development in Virology 3 (2001): 395–407. Henderson, Donald A. “Eradication: Lessons from the Past.” MMWR 48, Suppl. (December 31, 1999). Henderson, Donald A. “Lessons from the Eradication Campaigns.” Vaccine 17 (1999): S53–S55. Horstmann, D. M. “Poliomyelitis: Severity and Type of Disease in Different Age Groups.” Annals of New York Academy of Sciences 61 (1955): 956–967. Immunization Focus, a quarterly publication of the Global Alliance for Vaccines and Immunization (GAVI), December 2002. Interactif, no. 2, June 1998 (newsletter published by “Handicap International ” and the “Action Nord Sud” programs). The Jordan Report 2000, Accelerated Development of Vaccines, NIH, USA. Kew, Olen, et al. “Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus.” Science 296 (2002): 356–359. References 155 Koprowski, Hilary. “Histoire alternative du vaccine oral.” In L’aventure de la vaccination, under the direction of Anne-Marie Moulin. Paris: Fayard, 1996. Korber, B., M. Muldoon, J. Theiler, F. Gao, R. Gupta, A. Lapedes, B. H. Hahn, S. Wolinsky, and T. Bhattacharya. “Timing the Ancestor of the HIV-1 Pandemic Strains.” Science 288 (2000): 1789–1796. Louis, Cyrile. Jonas Salk, victoire sur la polio. Lyon: Pasteur Mérieux MSD, 1996. Mérieux, Charles. Virus Passion. Paris: Editions...